NCT05629442View on ClinicalTrials.gov

ctDNA and Organ Preservation/Pathologic CR in Rectal Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2030

Conditions
Rectal CancerNon Metastatic Rectal Cancer
Interventions
OTHER

ctDNA

initial research biopsy, quality of life assessments and ctDNA collection

Trial Locations (2)

02115

Massachusetts General Hospital, Boston

02462

Mass General Cancer Center Newton-Wellesley Hospital, Newton

Sponsors

Collaborators (1)

C2i Genomics
All Listed Sponsors
collaborator

C2i Genomics

INDUSTRY

collaborator

Spier Family Foundation

UNKNOWN

lead

Massachusetts General Hospital

OTHER